Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia.
| Image |  |
|---|---|
| Description | scientific article published on 30 August 2017 |
| Author/s |
author: Jan Cools David A Skerrett-Byrne Pieter Van Vlierberghe Nicole M Verrills Matthew D Dun Charles E de Bock Sofie Demeyer |
| Publication date | August 30, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |